{"id":"W4293553347","doi":"10.14740/jh1035","title":"Durable Remission in Hodgkin Lymphoma Treated With One Cycle of Bleomycin, Vinblastine, Dacarbazine and Two Doses of Nivolumab and Brentuximab Vedotin","year":2022,"lang":"en","type":"article","venue":"Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dacarbazine; Brentuximab vedotin; Vinblastine; ABVD; Nivolumab; Bleomycin; Internal medicine; Cyclophosphamide; Procarbazine; Lymphoma; Oncology; Vincristine; Chemotherapy; Radiology; Hodgkin lymphoma; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002096416,0.0001335536,0.0008611068,0.0002787772,0.00004355789,0.000003595727,0.00005582358,0.00004398597,0.00008339569],"category_scores_gemma":[0.00007482037,0.00009612089,0.00005120131,0.0002297744,0.0001028845,0.00005464296,0.00006586629,0.00009730343,2.123556e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009776652,"about_ca_system_score_gemma":0.0001639799,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002550721,"about_ca_topic_score_gemma":0.000037056,"domain_scores_codex":[0.9987185,0.00009746046,0.0006155639,0.0001543339,0.0002486853,0.0001654639],"domain_scores_gemma":[0.9988798,0.0001756193,0.0005691978,0.0001330896,0.0001418861,0.0001004266],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003926796,0.003039372,0.9605637,0.0002821914,0.0003013714,0.001197561,0.000322562,0.00005124845,0.02497898,0.0002284377,0.0003166641,0.004791157],"study_design_scores_gemma":[0.05396898,0.00846108,0.7852725,0.001125384,0.0005953416,0.02603481,0.0008233465,0.000450832,0.1225917,0.0002205049,0.0002797247,0.0001757764],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945436,0.004171055,0.000004908668,0.0008162688,0.00002658138,0.0001574256,0.000007614271,0.000004335808,0.0002681992],"genre_scores_gemma":[0.9986499,0.0004069032,0.0008283532,0.00004374679,0.0000136081,0.000007194552,0.000004532377,0.00001327052,0.00003251228],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1752911,"threshold_uncertainty_score":0.3919696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008509687977466355,"score_gpt":0.2426546961957102,"score_spread":0.2341450082182438,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}